Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study Neumora Therapeutics, Inc. has initiated a Phase 1 clinical study of NMRA-898, a M4 Positive Allosteric Modulator.
Designing Light-Filled Living Spaces: How Lifestyle Remodeling Is Shaping the Future of Tampa Sunrooms In Florida, natural light is one of…
Lululemon to Sell NFL Apparel in Fanatics Deal Lululemon has entered an arrangement with the NFL and Fanatics to develop a line of fan app…
Introduction to Circuit Design with Capacitors Among the abundance of components making up electronic circuits, very few are as important …
Vesper Solar 600 MW Texas Project The Vesper Solar 600 MW Texas project demonstrates how an agrivoltaics mindset can unlock prime sites fo…
Saudi Railway Company and Ericsson Partner on 5G Technology The Saudi Railway Company (SAR) has signed a memorandum of understanding (MoU)…
Councils' Role in New Towns Success Peers have emphasized the importance of councils in making the New Towns programme a success. A…
Rolex 24 Grid Expansion Not Possible Due to Pit Lane Space IMSA President John Doonan stated that expanding the Rolex 24 grid is currently…
Potential Human Pandemic from Bird Flu Strain A bird flu virus, H9N2, has the potential to spark a human pandemic, according to a team of …
ASX Market Update The Australian stock market is experiencing a decline, led by significant losses in the healthcare and tech sectors, des…
Scientists Say This 5-Minute Trick Could Help You Live Longer New research suggests it could be the key to boosting heart and lung health.…